← Open Payments lookup

ASHLEY TURNER: Open Payments

NPI 1952876518 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,129 in 34 payments from 16 companies in 2025. Trend: 2023 $639 · 2024 $551 · 2025 $1,129

Food & beverage: $1,129
CompanyPaymentsAmount
United Therapeutics Corporation9$361
Actelion Pharmaceuticals US, Inc.6$175
Merck Sharp & Dohme LLC1$110
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)1$99
Boehringer Ingelheim Pharmaceuticals, Inc.3$66
Takeda Pharmaceuticals U.S.A., Inc.2$57
Bayer Healthcare Pharmaceuticals Inc.2$47
Astellas Pharma US Inc1$33
Melinta Therapeutics, LLC2$33
ANI Pharmaceuticals, Inc.1$31

Products named: Tyvaso, UPTRAVI, Orenitram, LifeVest, LIVTENCITY, Remodulin, JASCAYD, Cresemba.

Industry payments across DC — which companies pay providers there.